Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryan Cawood

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Nature Communications|March 8, 2022
Self-attenuating adenovirus enables production of recombinant adeno-associated virus for high manufacturing yield without contaminationWeiheng Su, Maria I Patrício, Margaret R Duffy, et al.
Plos Pathogens|May 23, 2009
Use of tissue-specific microRNA to control pathology of wild-type adenovirus without attenuation of its ability to kill cancer cellsRyan Cawood, Hannah H Chen, Fionnadh Carroll, et al.
Trends in Molecular Medicine|August 25, 2012
Recombinant viral vaccines for cancerRyan Cawood, Thomas Hills, Suet Ling Wong, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 30, 2010
Active adenoviral vascular penetration by targeted formation of heterocellular endothelial-epithelial syncytiaHannah H Chen, Ryan Cawood, Yasser El-Sherbini, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 16, 2015
Increasing the density of nanomedicines improves their ultrasound-mediated delivery to tumoursSteven Mo, Robert Carlisle, Richard Laga, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 3, 2011
Tumour necrosis factor-alpha increases extravasation of virus particles into tumour tissue by activating the Rho A/Rho kinase pathwayTakahiro Seki, Fionnadh Carroll, Sam Illingworth, et al.
Nanomedicine (London, England)|June 20, 2012
Tropism ablation and stealthing of oncolytic adenovirus enhances systemic delivery to tumors and improves virotherapy of cancerNicola K Green, Ashley Hale, Ryan Cawood, et al.
Molecular Therapy Oncolytics|January 1, 2020
Calcium Influx Caused by ER Stress Inducers Enhances Oncolytic Adenovirus Enadenotucirev Replication and Killing through PKCα ActivationWilliam K Taverner, Egon J Jacobus, John Christianson, et al.
The Journal of Biological Chemistry|October 31, 2020
Development of a novel mammalian display system for selection of antibodies against membrane proteinsNathan Robertson, Nancy Lopez-Anton, Shalom A Gurjar, et al.
Nature Biotechnology|October 27, 2015
In vivo characterization of the physicochemical properties of polymer-linked TLR agonists that enhance vaccine immunogenicityGeoffrey M Lynn, Richard Laga, Patricia A Darrah, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Nature Communications|March 8, 2022
Self-attenuating adenovirus enables production of recombinant adeno-associated virus for high manufacturing yield without contaminationWeiheng Su, Maria I Patrício, Margaret R Duffy, et al.
Plos Pathogens|May 23, 2009
Use of tissue-specific microRNA to control pathology of wild-type adenovirus without attenuation of its ability to kill cancer cellsRyan Cawood, Hannah H Chen, Fionnadh Carroll, et al.
Trends in Molecular Medicine|August 25, 2012
Recombinant viral vaccines for cancerRyan Cawood, Thomas Hills, Suet Ling Wong, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 30, 2010
Active adenoviral vascular penetration by targeted formation of heterocellular endothelial-epithelial syncytiaHannah H Chen, Ryan Cawood, Yasser El-Sherbini, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 16, 2015
Increasing the density of nanomedicines improves their ultrasound-mediated delivery to tumoursSteven Mo, Robert Carlisle, Richard Laga, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 3, 2011
Tumour necrosis factor-alpha increases extravasation of virus particles into tumour tissue by activating the Rho A/Rho kinase pathwayTakahiro Seki, Fionnadh Carroll, Sam Illingworth, et al.
Nanomedicine (London, England)|June 20, 2012
Tropism ablation and stealthing of oncolytic adenovirus enhances systemic delivery to tumors and improves virotherapy of cancerNicola K Green, Ashley Hale, Ryan Cawood, et al.
Molecular Therapy Oncolytics|January 1, 2020
Calcium Influx Caused by ER Stress Inducers Enhances Oncolytic Adenovirus Enadenotucirev Replication and Killing through PKCα ActivationWilliam K Taverner, Egon J Jacobus, John Christianson, et al.
The Journal of Biological Chemistry|October 31, 2020
Development of a novel mammalian display system for selection of antibodies against membrane proteinsNathan Robertson, Nancy Lopez-Anton, Shalom A Gurjar, et al.
Nature Biotechnology|October 27, 2015
In vivo characterization of the physicochemical properties of polymer-linked TLR agonists that enhance vaccine immunogenicityGeoffrey M Lynn, Richard Laga, Patricia A Darrah, et al.
Pageof 3